7364
W. H. Pearson et al. / Tetrahedron Letters 42 (2001) 7361–7365
solved in dichloromethane (3 mL), mixed with triethyl-
amine (0.20 mL, 1.4 mmol), and added to the triflate
salt prepared above. After 12 h, the mixture was diluted
with ether and washed with 10% aqueous NaOH, and
the organic phase was dried (Na2SO4), filtered, and
concentrated. Chromatography (hexane to EtOAc to
15% MeOH/EtOAc gradient on alumina) afforded 190
mg (51%) of the title compound as an inseparable 1:1
mixture of diastereomers, Rf=0.20 (15% MeOH/EtOAc
on alumina). Partial data for one diastereomer: 1H
NMR (CDCl3, 360 MHz) l 3.34 (s, 3H). Partial data
for the other diastereomer: 1H NMR (CDCl3, 360
MHz) l 3.32 (s, 3H). Data for mixture: IR (neat) 1605
the American Chemical Society, and the Eastman
Kodak Company for financial support of this research.
References
1. Kauffmann, T. Angew. Chem., Int. Ed. Engl. 1974, 13,
627–639.
2. See the following recent papers and the earlier work cited
therein: (a) Pearson, W. H.; Lovering, F. E. J. Org.
Chem. 1998, 63, 3607–3617; (b) Pearson, W. H.; Ren, Y.
J. Org. Chem. 1999, 64, 688–689.
3. Asymmetric cycloadditions of ‘N-metalated azomethine
ylides’ have been reported. These are metalated imines of
glycine esters, and are more closely related to ester eno-
lates than 2-azaallyl anions. The primary asymmetric
approach in these systems involves the use of a chiral
dipolarophile. See: (a) Kanemasa, S.; Tsuge, O. In
Advances in Cycloaddition; Curran, D. P., Ed.; JAI Press:
Greenwich, CT, 1993; Vol. 3; pp. 99–159; (b) Kanemasa,
S.; Yamamoto, H. Tetrahedron Lett. 1990, 31, 3633–3636;
(c) Kanemasa, S.; Yamamoto, H.; Wada, E.; Sakurai, T.;
Urushido, K. Bull. Chem. Soc. Jpn. 1990, 63, 2857–2865;
(d) Barr, D. A.; Dorrity, M. J.; Grigg, R.; Malone, J. F.;
Montgomery, J.; Rajviroongit, S.; Stevenson, P. Tetra-
hedron Lett. 1990, 45, 6569–6572; (e) Waldmann, H.;
Blaeser, E.; Jansen, M.; Letschert, H.-P. Chem. Eur. J.
1995, 1, 150–4.
4. (a) Nozaki, H.; Aratani, T.; Toraya, T.; Noyori, R.
Tetrahedron 1971, 27, 905–913; (b) Hoppe, D.; Hintze,
F.; Tebben, P. Angew. Chem., Int. Ed. Engl. 1990, 29,
1422–1424; (c) Kerrick, S. T.; Beak, P. J. Am. Chem. Soc.
1991, 113, 9708–9710; (d) Beak, P.; Basu, A.; Gallagher,
D. J.; Park, Y. S.; Thayumanavan, S. Acc. Chem. Res.
1996, 29, 552–560; (e) Hoppe, D.; Hense, T. Angew.
Chem., Int. Ed. Engl. 1997, 36, 2282–2316.
5. The enantiomeric excess of 6 was determined by HPLC
using a Daicel Chiracel OD column (0.46×25 cm), 10%
isopropanol/hexane, 1 mL/min flow rate. [h]2D3 −0.39 (c
2.3, CDCl3).
6. The enantiomeric excess of 8 was determined by HPLC
using a Daicel Chiracel OJ column (0.46×25 cm), 10%
isopropanol/hexane, 1 mL/min flow rate.
7. Pearson, W. H.; Stevens, E. P. Tetrahedron Lett. 1994,
35, 2641–2644.
8. Pearson, W. H.; Stevens, E. P. J. Org. Chem. 1998, 63,
9812–9827.
1
(s) cm−1; H NMR (CDCl3, 360 MHz) l 4.10–4.00 (br
s, 1H), 3.64–3.55 (m, 1H), 3.46–3.40 (m, 1H), 3.40–3.28
(m, 4H), 3.28–3.05 (m, 2H), 1.88–1.72 (m, 7H), 1.50–
1.40 (m, 6H), 1.40–1.23 (m, 6H), 0.95–0.69 (m, 15H);
13C NMR (CDCl3, 90 MHz) l 151.4, 150.4, 74.1, 74.0,
58.9, 58.9, 56.1, 56.0, 47.9, 45.8, 29.3, 28.3, 28.1, 27.8,
27.6, 27.3, 27.1, 23.5, 23.4, 23.0, 22.8, 15.6, 13.8, 13.7,
8.9; MS (CI, NH3) m/z (rel. int.) 475 (9, M+H), 474 (7,
M+), 185 (38), 184 (97), 183 (100); HRMS (CI, NH3)
calcd for C22H47N2O120Sn (M+H)+ 475.2710, found
475.2709.
(2R,3S or 2S,3R)-2,3,5-Trimethyl-3-phenyl-3,4-dihydro-
2H-pyrrole (25): A solution of the amidine 24 (435 mg,
0.92 mmol) and a-methylstyrene (240 mg, 2.0 mmol) in
THF (2 mL) was added in a dropwise fashion to a
solution of n-butyllithium (1.7 mL, 4.6 mmol, 2.7 M in
hexanes) in THF (2 mL) at −78°C. After 2 h, excess
methanol was added and the mixture was diluted with
ether and washed with water. The organic phase was
dried (Na2SO4) and concentrated. Chromatography (0–
100% EtOAc/hexane gradient) first afforded 21 mg
(13%) of a mixture of two pyrrolines of undetermined
structure, Rf=0.15 (EtOAc), presumed to be
diastereomeric and/or regioisomeric with the pyrroline
1
22. Partial data for the first minor isomer: H NMR
(CDCl3, 360 MHz) l 1.92 (s, 3H), 1.53 (s, 3H), 1.37 (d,
3H, J=6.9 Hz). Partial data for the second minor
1
isomer: H NMR (CDCl3, 360 MHz) l 1.80 (s, 3H),
1.62 (s, 3H), 1.42 (d, 3H, J=6.9 Hz). Further elution
gave 80 mg (46%) of the title compound, the relative
configuration of which was determined by difference
NOE spectroscopy. Separation of the enantiomers of 22
by chiral HPLC revealed an enantiomeric excess of
98.2%. Data for 22: Rf=0.10 (EtOAc); IR (neat) 1646
9. Mattveev, I. S. Chem. Abstr. 1970, 72, 31662h.
10. Dahlke, G. D.; Kass, S. R. J. Am. Chem. Soc. 1991, 113,
5566–5573.
11. (a) Boche, G.; Fraenkel, G.; Cabral, J.; Harms, K.;
Hommes, N. J. v E.; Lohrenz, J.; Marsch, M.; Schleyer,
P. v R. J. Am. Chem. Soc. 1992, 114, 1562–1565; (b)
Kukbota, H.; Nakajima, M.; Koga, K. Tetrahedron Lett.
1993, 34, 8135–8138; (c) Fraenkel, G.; Qui, F. J. Am.
Chem. Soc. 2000, 122, 12806–12812.
1
(m) cm−1; H NMR (CDCl3, 360 MHz) l 7.34–7.21 (m,
5H), 4.08 (q, 1H, J=7.0 Hz), 3.12 (d, 1H, J=16.6 Hz),
2.58 (d, 1H, J=16.7 Hz), 2.10 (s, 3H), 1.39 (s, 3H), 0.72
(d, 3H, J=6.9 Hz); 13C NMR (CDCl3, 90 MHz) l
173.0, 145.6, 128.0, 126.7, 125.9, 49.8, 29.7, 20.5, 17.3;
MS (EI, 70 eV) m/z (rel int) 188 (6, M+1), 187 (28, M+)
172 (11), 69 (100); HRMS (EI, 70 eV) calcd for
C13H17N M+ 187.1361, found 187.1347.
12. Andrews, P. C.; Armstrong, D. R.; Mulvey, R. E.; Reed,
D. J. Am. Chem. Soc. 1988, 110, 5235–5236.
Acknowledgements
13. Andrews, P. C.; Mulvey, R. E.; Clegg, W.; Reed, D. J.
Organomet. Chem. 1990, 386, 287–297.
14. (a) Davenport, K. G.; Eichenauer, H.; Enders, D.; New-
comb, M.; Bergbreiter, D. E. J. Am. Chem. Soc. 1979,
101, 5654–5659; (b) Houk, K. N.; Strozier, R. W.; Ron-
We thank the National Institutes of Health (GM-
52491), the Petroleum Research Fund, administered by